Contact
Please use this form to send email to PR contact of this press release:
Catalyst Pharmaceuticals Announces FDA Orphan Drug Designation of Firdapse for the Treatment of Myasthenia Gravis
TO:
Please use this form to send email to PR contact of this press release:
Catalyst Pharmaceuticals Announces FDA Orphan Drug Designation of Firdapse for the Treatment of Myasthenia Gravis
TO: